The purpose of this study is to assess the efficacy of N-acetylcysteine (NAC) in preventing those with mild or moderate COVID-19 from progressing to severe disease
After being informed of the study and potential risks and benefits, patients meeting eligibility requirements will be randomized to receive oral N-acetylcysteine (NAC) as follows: Inpatients: * N-acetylcystine (NAC) 25 mg/kg PO (rounded up to the nearest 600 mg) q4hrs until discharge * N-acetylcysteine (NAC) 1200 mg PO BID x 1 week post-discharge Outpatients: \- N-acetylcysteine (NAC) 2400 mg PO x 1 then 1200 mg PO BID x 2 weeks
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
165
Oral formulation: 600 mg capsules of N-acetylcysteine
CHA Cambridge Hospital
Cambridge, Massachusetts, United States
CHA Everett Hospital
Everett, Massachusetts, United States
CHA Respiratory Clinic
Somerville, Massachusetts, United States
CHA Somerville campus
Somerville, Massachusetts, United States
Decrease in Respiratory Rate
Decrease in dyspnea measured by respiratory rate (RR)
Time frame: First hour after first dose of NAC
Hospital length of stay (LOS)
Hospital LOS for admitted patients
Time frame: Through study completion, average 9 months
Need for mechanical ventilation
Whether a patient needed mechanical ventilation (intubation)
Time frame: Through study completion, average 9 months
Length of time intubated
If intubated, how long needing mechanical ventilation
Time frame: Through study completion, average 9 months
Need for hospitalization
Outpatients on NAC needing admission to the hospital
Time frame: Through study completion, average 9 months
Recovery disposition
Whether outpatients continued to recover as outpatients; whether admitted patients were managed on medical floors or level of care increased to ICU level of care; whether patients expired
Time frame: Through study completion, average 9 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.